Parametric Portfolio Associates’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Parametric Portfolio Associates’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-89,296	Closed	-$42K	–	3881
2016 Q2	$42K	Buy	+89,296	New	+$42K	﹤0.01%	3787
2015 Q4	–	Sell	-68,465	Closed	-$108K	–	4066
2015 Q3	$108K	Sell	68,465 -282	-0.4%	-$445	﹤0.01%	3181
2015 Q2	$117K	Buy	68,747 +55,059	+402%	+$93.7K	﹤0.01%	3857
2015 Q1	$19K	Sell	13,688 -2,462	-15%	-$3.42K	﹤0.01%	3930
2014 Q4	$24K	Sell	16,150 -6,956	-30%	-$10.3K	﹤0.01%	3971
2014 Q3	$48K	Buy	+23,106	New	+$48K	﹤0.01%	3775
2014 Q2	–	Sell	-24,241	Closed	-$61K	–	3930
2014 Q1	$61K	Sell	24,241 -669	-3%	-$1.68K	﹤0.01%	3770
2013 Q4	$124K	Buy	+24,910	New	+$124K	﹤0.01%	3705

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parametric Portfolio Associates's RXII Position: Q3 2016 in Review

Parametric Portfolio Associates sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2016, closing a stake of 89,296 shares — an estimated $42K sold.

Parametric Portfolio Associates first reported a position in RXII in Q4 2013 and held it in 8 quarters. The position peaked at $124K in Q4 2013. 92 funds tracked by Wall St. Rank hold RXII as of Q3 2016.

Parametric Portfolio Associates reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2016 after selling out during the quarter.
Parametric Portfolio Associates sold 89,296 GALENA BIOPHARMA INC COM shares in Q3 2016, an estimated $42K.
Parametric Portfolio Associates first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 8 quarters.
Parametric Portfolio Associates's GALENA BIOPHARMA INC COM position peaked at $124K in Q4 2013.
92 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2016.

Based on Parametric Portfolio Associates's 13F filing for Q3 2016, filed 14 Nov 2016.